Advanced search
Publication Cover
Cancer Investigation Volume 27, 2009 - Issue 8
Submit an article Journal homepage
124
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES Clinical Translational Therapeutics

Increased Hemoglobin Associated with VEGF Inhibitors in Advanced Renal Cell Carcinoma

Lauren C. Harshman Division of Oncology, Stanford University School of Medicine, Stanford, California, USA
,
Calvin J. Kuo Division of Hematology, Stanford University School of Medicine, Stanford, California, USA
,
Bryan Y. Wong Division of Hematology & Oncology, Nevada Cancer Institute, Las Vegas, Nevada, USA
,
Nicholas J. Vogelzang Nevada Cancer Institute, Las Vegas, Nevada, USA
&
Sandy Srinivas Division of Oncology, Stanford University School of Medicine, Stanford, California, USA
Pages 851-856 | Published online: 01 Sep 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jonathan W. Riess, Aaron C. Logan, Yelena Krupitskaya, Sukhmani Padda, Christelle Clément-Duchêne, Kristen Ganjoo, A. Dimitrios Colevas, Melanie San Pedro-Salcedo, Calvin J. Kuo & Heather A. Wakelee. (2012) Maintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced, Nonsquamous, Non-Small Cell Lung Cancer. Cancer Investigation 30:3, pages 231-235.
Read now
Amna Sher & Shenhong Wu. (2011) Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy–A meta-analysis. Acta Oncologica 50:7, pages 997-1005.
Read now

Articles from other publishers (10)

Yoshitaka Saito, Shinya Tamaki, Daisuke Hirate, Shinya Takada, Kenta Takahashi, Yoh Takekuma, Jun Sakakibara-Konishi, Yasushi Shimizu, Ichiro Kinoshita & Mitsuru Sugawara. (2023) Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment. Scientific Reports 13:1.
Crossref
Fengju Chen, Darshan S. Chandrashekar, Sooryanarayana Varambally & Chad J. Creighton. (2019) Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nature Communications 10:1.
Crossref
Beth A. Hellerstedt, Nicholas J. Vogelzang, Harriet M. Kluger, Christopher A. Yasenchak, Dana T. Aftab, David A. Ramies, Michael S. Gordon & Primo LaraJr.Jr.. (2019) Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–small-cell Lung Carcinoma. Clinical Lung Cancer 20:2, pages 74-81.e1.
Crossref
Yong Wook Jung, Eun Hee Ahn, Jung Oh Kim, Hui Jeong An, Sung Hwan Cho, Young Ran Kim, Woo Sik Lee & Nam Keun Kim. (2018) Association of genetic polymorphisms in VEGF -460, -7 and -583 and hematocrit level with the development of idiopathic recurrent pregnancy loss and a meta-analysis . The Journal of Gene Medicine 20:9, pages e3048.
Crossref
Alison C. Johnson, Margarida Matias, Helen Boyle, Bernard Escudier, Alicia Molinier, Brigitte Laguerre, Carole Helissey, Pierre-Emmanuel Brachet, Audrey Emmanuelle Dugu?Loic Mourey, Elodie Coquan & Florence Joly. (2017) Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study. BMC Cancer 17:1.
Crossref
Abhishek Tripathi, Susanna Jacobus, Hope Feldman, Toni K. Choueiri & Lauren C. Harshman. (2017) Prognostic Significance of Increases in Hemoglobin in Renal Cell Carcinoma Patients During Treatment With VEGF-directed Therapy. Clinical Genitourinary Cancer 15:3, pages 396-402.
Crossref
Zuo-Pei Wang, Hai-Feng Zhang, Feng Zhang, Bao-Li Hu, Hai-Tao Wei & Yong-Yuan Guo. (2015) Bevacizumab did not reduce the risk of anemia associated with chemotherapy: an up-to-date meta-analysis. European Journal of Clinical Pharmacology 71:5, pages 517-524.
Crossref
Sumita S. Bhatta, Kristen E. Wroblewski, Kelly L. Agarwal, Laura Sit, Ezra E.W. Cohen, Tanguy Y. Seiwert, Theodore Karrison, George L. Bakris, Mark J. Ratain, Everett E. Vokes & Michael L. Maitland. (2013) Effects of Vascular Endothelial Growth Factor Signaling Inhibition on Human Erythropoiesis. The Oncologist 18:8, pages 965-970.
Crossref
C. Cl?ment-Duch?ne, B. Godbert & Y. Martinet. (2012) Th?rapeutiques antiangiog?niques dans le cancer bronchique?: indications et toxicit?s. Revue des Maladies Respiratoires 29:2, pages 161-177.
Crossref
Christelle Cl?ment-Duch?ne & Heather Wakelee. (2010) Antiangiogenic Agents and Vascular Disrupting Agents for the Treatment of Lung Cancer: A Review. Journal of Thoracic Oncology 5:1, pages 129-139.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.